Lantheus Completes Acquisition of Evergreen Theragnostics. Please see the press release to learn more.

Patent Information

Purpose of this notice

This page is intended to serve as notice under 35 U.S.C. §287(a). The following U.S. patents apply to our products:

DEFINITY®/DEFINITY® RT:

U.S. Patent Nos.: 9,789,210; 9,913,919; 10,022,460; 10,220,104; 10,583,207; 10,583,208; 10,588,988; 11,266,749; 11,266,750; 11,344,636; 11,395,856; 11,529,431; 11,857,646; 11,925,695;12,097,270; 12,161,730. Other patents pending.

PYLARIFY®:

U.S. Patent Nos.: 8,487,129; 8,778,305; 9,861,713; 10,947,197; 11,851,407; 12,070,513. Other patents pending.

TechneLite®:

U.S. Patent Nos.: 8,569,713; 8,822,950. Other patents pending.

Xenon 133:

U.S. Patent No.: 10,276,274.

Lead 203:

U.S. Patent Nos.: 10,199,130; 10,910,123.

aPROMISE / PYLARIFY AI®, CURE8®, and aBSI:

U.S. Patent Nos.: RE47,609,10,340,046; 10,665,346; 10,762,993; 10,973,486; 11,321,844; 11,386,988; 11,424,035; 11,534,125; 11,544,407; 11,564,621; 11,657,508; 11,721,428; 11,894,141; 11,900,597; 11,937,962; 11,941,817; 11,948,283; 12,032,722; 12,224,067. Other patents pending.